Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma

• Published in: Experimental Oncology
• Date: 2012
• Main Authors: Petrushev, B., Tomuleasa, C., Soritau, O., Aldea, M., Pop, T., Susman, S., Kacso, G., Berindan, I., Irimie, A., Cristea, V.
• Format: Article
• Language: English
• Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2012
• Subjects: Original contributions
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/138685
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma / B. Petrushev, C. Tomuleasa, O. Soritau, M. Aldea, T. Pop, S. Susman, G. Kacso, I. Berindan, A. Irimie, V. Cristea // Experimental Oncology. — 2012. — Т. 34, № 1. — С. 17-24. — Бібліогр.: 35 назв. — англ.

Objectives: Metformin, the most used oral antidiabetic drug for the treatment of type 2 diabetus mellitus, has proved encouraging results when used in the treatment of various types of cancer such as triple-negative breast cancer. Despite compelling evidence of a role of metformin as an anticancer d...